Mednet Logo
CommunityRadiation Oncology

When do you consider elective pelvic nodal irradiation for unfavorable intermediate risk prostate cancer?

Do you use decipher, or other genetic testing to determine whether you will include pelvic lymph nodes when you give definitive EBRT? Can you comment on using decipher to determine whether to give ADT and the length of ADT?
4 Answers
Mednet Member
Mednet MemberInvited Expert
Radiation Oncology · Virginia Commonwealth University Medical Center
Answered on

I consider elective pelvic nodal irradiation for patients classified as unfavorable intermediate risk by virtue of having Grade Group (GG) 3 disease, especially if they have high volume disease (50% or more of the cores are positive). These patients have a risk of lymph nodal involvement that is in ...

Join for free or sign in to see the full answer

Mednet Member
Mednet Member
Radiation Oncology · Orlando Health UF Health Cancer Center Health Central Hospital
Answered on

I agree with @Dr. First Last's response. High-volume GG3 often will lead me to consider adding pelvic RT. I think the MSKCC pre-RP nomogram is also helpful- as it will give you an estimate of LN involvement. What is the “right” cut-off for adding pelvic RT, if the risk is >15%? >20%? That is a judge...

Join for free or sign in to see the full answer

Mednet Member
Mednet Member
Radiation Oncology · Vanderbilt-Ingram Cancer Center
Answered on

I am not aware of data suggesting Decipher predicts for lymph node involvement. Worse outcome, yes. LN involvement specifically, no.

GU-010 is evaluating whether Decipher can be used as a predictive marker as to the benefits of ADT, but until results are published, I would not use it as a predictive ...

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Radiation Oncology · University of Florida
Answered on

When the risk is 10% or higher based on the MSK and/or Briganti nomograms.

Join for free or sign in to see the full answer